NANoor Ul Ain

Noor Ul Ain

*This is an algorithmically generated author record based on publicly available information.

Noor Ul Ain has a total of 1 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biochemistry of Vitamin B: Metabolic Regulations, Deficiency Disorders and Emerging Therapeutic Strategies

    by Zainab Syed, Noor Ul Ain

    The vitamin B complex represents a distinct group of water-soluble micronutrients, including thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), biotin (B7), folic acid (B9), and cobalamin (B12), that function as essential coenzymes in numerous catabolic and anabolic reactions. These vitamins are central to carbohydrate, lipid, and protein metabolism and play a crucial part in neurotransmitter synthesis, energy production, carbon uptake, and overall neurological processes. Through interconnected molecular pathways, the B complex acts as cofactors in numerous metabolic reactions that maintain body homeostasis and tissue functions. In addition to their metabolic functions, B- vitamins are also involved in DNA synthesis and repair, cellular differentiation, and redox balance. For example, cobalmin and folic acid are essential for one-carbon metabolism, directly influencing nucleic acid synthesis and epigenetic regulations. Pyridoxine plays an important role in amino acid metabolism and neurotransmitter synthesis, including dopamine, serotonin, and gamma aminobutyric acid, all of which are important for mental health and cognitive function. Riboflavin and niaiin are indespensable for cellular respiration and oxidative phosphorylation. Disruption of these pathways due to deficiency can result in serious neurological, hematological, and neuropsychiatric disorders in the susceptible population. Emerging therapeutics, including high-dose pharmacologic approaches, bioactive vitamin forms, and nanotechnology-based carriers (including nanoparticles, liposomes, and encapsulation techniques), are being developed to address deficiency through targeted interventions and to optimize the therapeutic potential in metabolic and chronic disease management. These innovative strategies improve abosprtion, minimize potential side effects, and reduce dosing frequency, thereby expanding their basic role beyond basic supplementation to therapeutic applications.